Advertisement
Taking proton pump inhibitors is associated with an excess of cause-specific mortality

Excess Cause-Specific Mortality Tied to Chronic Proton Pump Inhibitor Use

0
Excess mortality due to CVD, CKD, upper GI cancer for those with no indication for PPI use
Five months into 2019

CDC: Reported Measles Cases Reach 971

0
With continued outbreaks, CDC says U.S. risks losing measles elimination status
About half of immunosuppressed persons reported participating in cleanup activities following Hurricane Harvey

Many Immunosuppressed Persons Join in Hurricane Cleanup

0
Use of respirators low, with about half of those engaged in heavy cleanup wearing respirator
The first test to detect the Zika virus in human blood has been approved by the U.S. Food and Drug Administration.

FDA Approves First Test for Zika in Human Blood

0
The ZIKV Detect 2.0 IgM Capture ELISA is made by Seattle-based InBios
Integrated stepped alcohol treatment reduces alcohol consumption in patients with HIV and a known drinking problem

Stepped Tx for Alcohol Use Disorder Studied in HIV Patients

0
Gradually increasing intensity of treatment reduces alcohol intake and improves HIV status
High costs are associated with physician turnover and reduced clinical hours attributed to burnout

High Costs Associated With Physician Burnout in U.S.

0
Nationally, about $4.6 billion in costs are related to physician turnover, reduced clinical hours
Reading clinical notes can help patients to understand why medications are prescribed and improves medication adherence for some patients

Reading Visit Notes May Improve Medication Management

0
Patients say note reading helps them understand why meds are prescribed, makes them feel in control
For patients with type 2 diabetes

Hip Fracture Linked to Increased Risk for Death in T2DM Patients

0
Correlation not affected by adjustment for cardiovascular disease, end-stage renal disease
The global burden of serious health-related suffering is set to increase 47 percent by 2060

Global Burden of Serious Health-Related Suffering to Double by 2060

0
Fastest increases seen in low-income countries, among older people, and for those with dementia
The U.S. Food and Drug Administration has cleared for marketing two tests that detect the presence of Chlamydia trachomatis and Neisseria gonorrhoeae with diagnostic testing of extragenital specimens.

Extragenital Tests to Detect Chlamydia, Gonorrhea Cleared for Marketing

0
Tests previously approved for testing urine, vaginal, and endocervical samples